| Patents for C07C 233 - Carboxylic acid amides (28,881) |
|---|
| 02/19/2004 | US20040034091 Derivative of dicarboxylic acids having six to twelve carbon atoms and use of these derivatives and dicarboxylic acids alone in the preparation of pharmaceutical compositions for enteral and parenteral nutrition |
| 02/19/2004 | US20040033995 Nitrogen compounds, stereoisomers and/or racemic mixtures used as enzyme inhibitors for prophylaxis of inflammatory diseases |
| 02/19/2004 | CA2493008A1 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/18/2004 | EP1389180A1 Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use |
| 02/18/2004 | EP1389176A1 Method for producing ketones from carboxylic acid anhydrides |
| 02/18/2004 | EP1171416B1 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors |
| 02/18/2004 | EP1082293B1 Formoterol polymorphs |
| 02/18/2004 | EP0918781B1 Asymmetric synthesis catalyzed by transition metal complexes with cyclic chiral phosphine ligands |
| 02/18/2004 | CN1476424A 萘衍生物 Naphthalene Derivatives |
| 02/18/2004 | CN1475478A Preparation method of 2-alkyl acyl-4-alkylamio phenol |
| 02/18/2004 | CN1138546C Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 02/17/2004 | US6693105 Using xanthinyl derivatives to reduce treatment induced toxicity; inhibiting cellular signaling through second messenger pathway; reducing cellular level of nonarachi-donate phosphatidic acid and diacylglycerol |
| 02/17/2004 | US6693092 Herbicides; pesticides |
| 02/17/2004 | US6692734 N,O-amidomalonate platinum complexes |
| 02/12/2004 | WO2004013094A2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/12/2004 | WO2004013077A2 Cyclopentanone and cyclopentanone derivatives as potent activators of hsf-1 |
| 02/12/2004 | WO2003101381A3 1,2 diamido cycloalkyl sodium channel blockers |
| 02/12/2004 | WO2003049702A3 Vanilloid receptor ligands and their use in treatments |
| 02/12/2004 | WO2003030151A3 Lubricant for magnetic recording medium and use thereof |
| 02/12/2004 | WO2002058698A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 02/12/2004 | US20040030183 Method for producing N-butyryl-4-amino-3-methyl-methyl benzoate and the novel compound N-(4-bromo-2-methylphenyl)butanamide |
| 02/12/2004 | US20040030182 Methods for producing nateglinide crystals |
| 02/12/2004 | US20040030141 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them |
| 02/12/2004 | US20040029929 Aminoadamantane derivatives as therapeutic agents |
| 02/12/2004 | US20040028714 Composition having insect repellent characteristics |
| 02/12/2004 | US20040028638 Carboxylic acid-type lipid |
| 02/12/2004 | CA2495030A1 Cyclopentanone and cyclopentanone derivatives as potent activators of hsf-1 |
| 02/12/2004 | CA2494404A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/11/2004 | EP1388535A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 02/11/2004 | EP1047411B1 Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation |
| 02/11/2004 | EP1006110B1 Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments |
| 02/11/2004 | CN1474803A Novel amide derivatives and medicinal use thereof |
| 02/11/2004 | CN1474797A Retiferol derivatives and their use in treatment of skin diseases or conditions associated with photodamage |
| 02/11/2004 | CN1473814A Intemediate for preparing alkyl-dihalogeno phenyl substituted keto-enol |
| 02/11/2004 | CN1137889C Novel tricycloacylamide compound, its preparation method and medicinal composition containing them |
| 02/11/2004 | CN1137878C Aryloxyaniline derivatives |
| 02/10/2004 | US6689908 Polyalkoxylated superamides optionally functionalized, use as emulsifiers |
| 02/10/2004 | US6689900 Fluorinated crosslinker and composition |
| 02/10/2004 | US6689724 Antioxidants and antioxidant boosters capable of producing hydroperoxyl radicals |
| 02/10/2004 | US6689174 N-benzyl-p-phenylenediamine-derivatives containing coloring agents for keratin fibres and novel n-benzyl-p-phenylenediamine-derivatives |
| 02/10/2004 | CA2079447C Sustained drug release through topical application of bioadhesive liposomes |
| 02/05/2004 | WO2004011523A2 Novel phase change solvents |
| 02/05/2004 | WO2004011416A1 CRYSTALLINE β2 ADRENERGIC RECEPTOR AGONIST |
| 02/05/2004 | WO2004011415A1 Flavourant compounds |
| 02/05/2004 | WO2004011414A1 E-ISOMERIC β-AROMATIC OR HETEROAROMATIC SUBSTITUTED β-ACYLAMINO-ACRYLATES AND METHODS OF PREPARING THE SAME |
| 02/05/2004 | WO2004011410A1 Chemical compounds |
| 02/05/2004 | WO2003082823A3 Pro-dyes containing compositions for dyeing keratinous fibers |
| 02/05/2004 | US20040024219 Reacting acid chloride with phenylalanine in solvent comprising potassium hydroxide; for production drugs |
| 02/05/2004 | US20040023933 Use for the treatment of diseases having an inflammatory basis of compounds or salts thereof, having the following general formula (I): A-Xt-L-(W)p-NO2 wherein A contains the radical of a drug, Xt and W arc bivalent radicals, L, is a |
| 02/05/2004 | US20040023831 Sulfuric acid amine salt, sulfonic acid amine salt, production thereof and softener composition |
| 02/05/2004 | US20040023290 Novel therapeutic agents that modulate enzymatic processes |
| 02/05/2004 | US20040022856 Carriers for drug delivery |
| 02/05/2004 | US20040021130 Novel phase change solvents |
| 02/05/2004 | CA2494668A1 Chemical compounds |
| 02/05/2004 | CA2493128A1 Crystalline .beta.2 adrenergic receptor agonist |
| 02/04/2004 | EP1386908A1 Amine derivative with potassium channel regulatory function, its preparation and use |
| 02/04/2004 | EP1385825A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 02/04/2004 | EP1385498A2 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 02/04/2004 | EP1385493A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties |
| 02/04/2004 | EP1163210B1 Rosin amine anti-fouling agents |
| 02/04/2004 | EP0994888B1 Process for the acylation of amino alcohols |
| 02/04/2004 | EP0992503B1 Process for producing isooxazolidinedione compound |
| 02/04/2004 | CN1473145A Method of resolving optical isomers of amino acid derivative |
| 02/04/2004 | CN1473034A Photo-labile pro-fragrance conjugates |
| 02/03/2004 | US6686477 Multistep chemical synthesis, including asymmetric hydrogenation of a lactam-enamide to produce an intermediate that can be used to make unspecified pharmaceuticals |
| 02/03/2004 | US6686467 Inhibitors of the production of cytokines such as tumour necrosis factor (hereinafter tnf), for example tnf alpha , and various members of the interleukin (hereinafter il) family, for example il-1, il-6 and il-8 |
| 02/03/2004 | US6686350 Cell adhesion inhibitors |
| 02/03/2004 | US6685953 Water retention capacity; moisturizer; alkoxyalkyamides of alkylenedicarboxylic acids |
| 02/03/2004 | CA2355987C Bicyclic amide derivatives and their use as muscle relaxants |
| 02/03/2004 | CA2084109C Novel process for preparing 4-amino-5-hexanoic acid |
| 01/29/2004 | WO2004009532A1 Polymorphic forms of nateglinide |
| 01/29/2004 | WO2003066035A3 Compounds for inhibiting insulin secretion and methods related thereto |
| 01/29/2004 | US20040019216 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 01/29/2004 | US20040019205 Cycloaliphatic/aromatic diphosphines and use thereof in catalysis |
| 01/29/2004 | US20040019114 4-Fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical |
| 01/29/2004 | US20040019072 Dimer-selective RXR modulators and methods for their use |
| 01/29/2004 | US20040018543 Incubation; controlling temperature and pH |
| 01/29/2004 | CA2492644A1 Polymorphic forms of nateglinide |
| 01/28/2004 | EP1384722A1 Process for the production of 2-(5-methyl-4-oxazolyl)acetates |
| 01/28/2004 | EP1383731A1 Biaryl compounds as serine protease inhibitors |
| 01/28/2004 | EP1095160B1 Method for producing (1r,4s)-2-azabicyclo 2.2.1 hept-5-en-3-on derivatives. |
| 01/28/2004 | CN1471507A Improved process for production of gabapentin intermediate |
| 01/28/2004 | CN1136451C Use of certain amides |
| 01/28/2004 | CN1136318C Process for producing optically active amines |
| 01/28/2004 | CN1136193C Imide derivatives ar Salts thereof |
| 01/28/2004 | CN1136189C Substituted heterocyclic compounds, preparing method thereof and pharmaceutical composition containig them |
| 01/28/2004 | CN1136186C Method for preparing intermediate of methylsalfomanido phenethylamine derivative |
| 01/27/2004 | US6683212 Fungicidally active carboxylic acid amides |
| 01/27/2004 | US6683211 Fungicides for crops |
| 01/27/2004 | US6683201 Analine derivatives as OSC inhibitors |
| 01/27/2004 | US6683196 Reacting racemic beta-lactam with lithium- 7-protected baccatin iii- complex to form 3'desphenyl-3'-(1-napthyl)taxol; antitumor agents |
| 01/27/2004 | US6683099 Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/27/2004 | US6683033 Concentrated aqueous betaine surfactant compositions and process for their preparation |
| 01/27/2004 | CA2413901C An acid washed adsorbent carbon used in a method for the purification of acetaminophen |
| 01/22/2004 | WO2004007449A1 Process for conversion of phenols to carboxamides via the succinimide esters |
| 01/22/2004 | WO2004007417A1 Enzyme inhibitors |
| 01/22/2004 | US20040015015 Vasoconstrictors that are used to prolong the activity of local anesthetics in dental preparations |
| 01/22/2004 | US20040014969 Such as methyl-4'-(4-((8-(acetylamino)ethyl)-2-naphthyl)oxy) butoxy)-(1,1'-biphenyl)-4-carboxylate; for treating/ preventing melatoninergic disorders |
| 01/22/2004 | US20040014809 Novel n-( 2-phenyl-3-aminopropyl)naphtamides |
| 01/21/2004 | EP1382333A2 Use of beta 3 adrenergic receptor agonists in the treatment of dysuria |